Orex Pharma Private Limited, a active private limited company, was established on 20 June 1979 in Thane, Maharashtra, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U99999MH1979PTC021403. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.10 Cr and a paid-up capital of ₹2.29 Cr.
It upholds a compliant status. Employing 138 professional, Its leadership includes Baburao Krishnaji Pisal (Managing Director), Mangesh Baburao Pisal (Director), Kiran Baburao Pisal (Director). Past directors included Suman Baburao Pisal, Kiran Baburao Pisal. It holds ₹47.19 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Pisal House, Nakhwa Compound, Stadium Road, Thane (W),, Thane, Maharashtra, 400601.
U99999MH1979PTC021403
021403
20 June 1979
₹3.10 Cr
₹2.29 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Orex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Baburao Krishnaji Pisal | Managing Director | 20 Jun 1979 | Current |
| Mangesh Baburao Pisal | Director | 01 Oct 2004 | Current |
| Kiran Baburao Pisal | Director | 01 Oct 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Orex Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 10.13% increase. The company also saw a substantial fall in profitability, with a 13.96% decrease in profit. The company's net worth Soared by an impressive increase of 11.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Orex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹471,884,725.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2025 | Others | ₹2.50 M | Open |
| 31 Jan 2024 | Others | ₹2.00 Cr | Open |
| 10 Oct 2022 | Others | ₹7.50 M | Open |
| 10 Oct 2022 | Others | ₹6.24 Cr | Open |
| 10 Oct 2022 | Others | ₹11.00 Cr | Open |
Explore comprehensive loan charge details -
Orex Pharma has a workforce of 138 employees as of Mar 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Orex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 11.00 Cr registered on 10 Oct 2022 with Charge ID 100622406 was modified on 22 Sep 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 0.25 Cr with Charge ID 101124604 was registered on 16 Jun 2025. was recorded as a recent event.
Progress on Orex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Orex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
A charge with Others of Rs. 2.00 Cr registered on 31 Jan 2024 with Charge ID 100864811 was modified on 21 Mar 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100864811 was registered on 31 Jan 2024. was recorded as a recent event.
When you find out your friend Canasil is hanging out with someone else (Orex) and didn't tell you #FOMO #TSXV #OTCQX #loyaltywho.
The CIN of Orex Pharma Private Limited is U99999MH1979PTC021403.
Orex Pharma Private Limited is headquartered at Pisal House, Nakhwa Compound, Stadium Road, Thane (W),, Thane, Maharashtra, 400601.
Orex Pharma Private Limited was incorporated on 20 June 1979.
The current directors of Orex Pharma Private Limited are
The primary industry of Orex Pharma Private Limited is Manufacturing.
Orex Pharma Private Limited is unlisted.
The authorized capital of Orex Pharma Private Limited is ₹3.10 Cr, and the paid-up capital is ₹2.29 Cr.
The compliance status of Orex Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX